Daily Newsletter

02 November 2023

Daily Newsletter

02 November 2023

NSW to open isolation rooms at Sydney’s children’s hospitals

These rooms will be built at The Children's Hospital at Westmead and Sydney Children's Hospital, Randwick.

November 01 2023

The government of New South Wales (NSW), Australia is setting up positive pressure isolation rooms at children's hospitals in Sydney.

These rooms, called Positive Pressure Ventilation Anterooms (PPVA), will be built at The Children's Hospital at Westmead and Sydney Children's Hospital, Randwick, in cancer care wards and intensive care units.

They use specialised air ventilation systems to create positive air pressure, preventing outside pathogens such as viruses from entering patient rooms.

These rooms aim to protect immunocompromised children, such as cancer or transplant patients, by reducing infection risks.

The NSW government has allocated A$3bn ($1.9m) in the September budget for upgrading hospitals, including this initiative.

Prototypes of these rooms have been developed at The Children's Hospital at Westmead for staff to become familiar with the design and technology, allowing for layout adjustments and training.

Additionally, carer zones will be introduced in intensive care units, allowing parents and carers to stay with children in the hospital.

NSW Premier Chris Minns said: “The NSW Government is committed to rebuilding essential health services with significant investments in both staff and infrastructure.

“This technology is something that paediatric healthcare has never had before in NSW, making it a first for both the Sydney Children’s Hospitals Network and the state.

“For kids who are immunosuppressed, being able to reduce the risk of getting a virus or a cold is so important during what is usually intense treatment, and that’s why we want to ensure our hospitals have the ability to protect sick kids and their families as much as possible.”

These isolation rooms are slated for completion in both hospitals by 2025.

Is the healthcare industry ready to fully embrace the benefits of digitalization and AI?

The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close